Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.48 USD | +0.10% |
|
+9.94% | +33.74% |
07-08 | Mirum Pharmaceuticals Gets Marketing Approval for Livmarli in Europe | MT |
07-08 | Mirum Pharmaceuticals, Inc.' LIVMARLI Approves in the European Union for Patients with PFIC | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.74% | 1.86B | |
+22.15% | 46.56B | |
+44.76% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- MIRM Stock
- News Mirum Pharmaceuticals, Inc.
- Mirum Pharmaceuticals Gets Marketing Approval for Livmarli in Europe